OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolism, Epigenetics, and Causal Inference in Heart Failure
Todd H. Kimball, Thomas M. Vondriska
Trends in Endocrinology and Metabolism (2019) Vol. 31, Iss. 3, pp. 181-191
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Cardiac fibroblasts and mechanosensation in heart development, health and disease
Maurizio Pesce, Georg N. Duda, Giancarlo Forte, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 5, pp. 309-324
Closed Access | Times Cited: 72

Mitochondrial Ca2+ regulation in the etiology of heart failure: physiological and pathophysiological implications
Haixia Xu, Sumei Cui, Yingmei Zhang, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 10, pp. 1301-1309
Open Access | Times Cited: 81

Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
Zehua Liang, Yuquan He, Xin Hu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10617-10617
Open Access | Times Cited: 32

Function of histone methylation and acetylation modifiers in cardiac hypertrophy
Jian Qin, Ningning Guo, Jingjing Tong, et al.
Journal of Molecular and Cellular Cardiology (2021) Vol. 159, pp. 120-129
Closed Access | Times Cited: 38

Real-time exercise reduces impaired cardiac function in breast cancer patients undergoing chemotherapy: A randomized controlled trial
Wei‐Pang Chung, Hsin-Lun Yang, Ya‐Ting Hsu, et al.
Annals of Physical and Rehabilitation Medicine (2021) Vol. 65, Iss. 2, pp. 101485-101485
Open Access | Times Cited: 35

The remodel of the “central dogma”: a metabolomics interaction perspective
Gilson Costa dos Santos, Mariana Renovato‐Martins, Natália Mesquita de Brito
Metabolomics (2021) Vol. 17, Iss. 5
Open Access | Times Cited: 33

Mitochondria-associated endoplasmic reticulum membranes (MAMs): Possible therapeutic targets in heart failure
Yu Zhang, Jiayu Yao, Mingming Zhang, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 15

Nuclear ATR lysine-tyrosylation protects against heart failure by activating DNA damage response
Rui Zhao, Ke Cai, Jing‐Jing Yang, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112400-112400
Open Access | Times Cited: 15

High serum lactate dehydrogenase as a predictor of cardiac insufficiency at follow-up in elderly patients with acute myocardial infarction
Hailin Zhang, Kai Kang, Shuaijie Chen, et al.
Archives of Gerontology and Geriatrics (2023) Vol. 117, pp. 105253-105253
Closed Access | Times Cited: 14

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
Himani Kumari, Wan-Hong Huang, Michael W.Y. Chan
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 38

Endoplasmic Reticulum-Mitochondria Contacts: A Potential Therapy Target for Cardiovascular Remodeling-Associated Diseases
Yu Wang, Xinrong Zhang, Ya Wen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 29

Unraveling the metabolic‒epigenetic nexus: a new frontier in cardiovascular disease treatment
Jun Ouyang, Dong-de Wu, Y. Gan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access

Circulating metabolic signatures of heart failure in precision cardiology
Huijing Xie, Bowen Zhang, Maodi Xie, et al.
Precision Clinical Medicine (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 9

Mitochondrial Dysfunction in Cardiac Disease: The Fort Fell
Ioannis Paraskevaidis, Christos Kourek, Dimitrios Farmakis, et al.
(2024)
Open Access | Times Cited: 2

Irisin: linking metabolism with heart failure.
Jiamin Li, Su-Su Xie, Lei Guo, et al.
PubMed (2020) Vol. 12, Iss. 10, pp. 6003-6014
Closed Access | Times Cited: 13

Epigenetic Mechanisms Involved in the Cardiovascular Toxicity of Anticancer Drugs
Παναγιώτα Παπάζογλου, Luying Peng, Agapios Sachinidis
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 12

Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy
Renaud David, Sabine Scholl‐Bürgi, Daniela Karall, et al.
Metabolites (2023) Vol. 13, Iss. 8, pp. 932-932
Open Access | Times Cited: 4

Mitochondrial Dysfunction in Cardiac Disease: The Fort Fell
Ioannis Paraskevaidis, Christos Kourek, Dimitrios Farmakis, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1534-1534
Open Access | Times Cited: 1

NAP1L5 Promotes Nucleolar Hypertrophy and Is Required for Translation Activation During Cardiomyocyte Hypertrophy
Ningning Guo, Di Zheng, Jiaxin Sun, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 9

Reverse cardio-oncology: A budding concept
Chhabi Satpathy, Trinath Kumar Mishra, Subhasish Singh, et al.
Indian Heart Journal (2023) Vol. 75, Iss. 6, pp. 398-402
Open Access | Times Cited: 3

Identifying temporal molecular signatures underlying cardiovascular diseases: A data science platform
Neo Christopher Chung, Howard Choi, Ding Wang, et al.
Journal of Molecular and Cellular Cardiology (2020) Vol. 145, pp. 54-58
Open Access | Times Cited: 8

Metabolic remodeling in takotsubo syndrome
Ti Wang, Ting Xiong, Yuxue Yang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 5

Cardiovascular informatics: building a bridge to data harmony
J. Harry Caufield, Dibakar Sigdel, John Fu, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 3, pp. 732-745
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top